•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Plan
Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
Lineage: Don't Mistake A Cyclical Slump For A Broken Business
Grand Design RV Unveils the All-New Lineage Series E, Redefining Innovation in Motorized RV Travel
Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp
Lineage to Report Second-Quarter 2026 Financial Results on August 5, 2026
Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
Lineage vs. Rexford Industrial Realty: Which Real Estate Stock Is a Better Buy in 2026?
Lineage: Another Serious Fire Could Spell Trouble
PREFORMED LINE PRODUCTS ANNOUNCES QUARTERLY DIVIDEND
LAIRD SUPERFOOD® EXPANDS PRODUCT LINE AT TARGET TO INCLUDE FUNCTIONAL MUSHROOM COFFEES
Lineage, Inc. Declares Dividend for Second-Quarter 2026
Kuehn Law Encourages Investors of Lineage, Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Lineage, Inc. to Contact Law Firm
Anti-AI Investing: The HALO Moat
Linear Announces Acquisition, Share Consolidation and Private Placement
Lineage Cell Therapeutics Q1 Earnings Call Highlights
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Zouga & Wolf Defines a New Standard for Private Tailoring in the Era of Lineage Luxury